Skip to content
HowShorted

Avalo Therapeutics, Inc. short interest in 2020

In 2020, Avalo Therapeutics, Inc.'s disclosed short interest ran from 1.16% of shares outstanding on 15 Jan 2020 to 1.81% on 31 Dec 2020, a change of +0.65 percentage points. The year's high was 2.55% on 30 Jun 2020 and its low 0.49% on 31 Mar 2020, averaging 1.43% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.56 days on 30 Nov 2020. Full history: Avalo Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Avalo Therapeutics, Inc. in 2020

2020 in figures

Start of year
1.16% (15 Jan 2020)
End of year
1.81% (31 Dec 2020)
Change
+0.65 pp
High
2.55% (30 Jun 2020)
Low
0.49% (31 Mar 2020)
Average
1.43%
Highest days to cover
9.56 (30 Nov 2020)
SEC filings marked
9

Every report in 2020

Avalo Therapeutics, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20201.16%5.89
31 Jan 20200.99%8.92
14 Feb 20200.69%3.47
28 Feb 20200.66%3.71
13 Mar 20200.56%3.2210-K filed, results (8-K)
31 Mar 20200.49%1.53
15 Apr 20200.57%2.75
30 Apr 20200.74%2.93
15 May 20200.89%2.8310-Q filed, results (8-K)
29 May 20200.81%1.07
15 Jun 20201.12%1.00results (8-K)
30 Jun 20202.55%2.59
15 Jul 20202.07%3.40
31 Jul 20202.04%1.31
14 Aug 20201.64%1.5210-Q filed, results (8-K)
31 Aug 20201.74%4.68
15 Sep 20201.96%3.49
30 Sep 20201.83%3.57
15 Oct 20202.08%9.36
30 Oct 20202.19%6.10
13 Nov 20201.83%9.4010-Q filed, results (8-K)
30 Nov 20202.08%9.56
15 Dec 20201.83%5.03
31 Dec 20201.81%3.29

See also: Avalo Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.